Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 27.23 +2.92 (12.01%)
Previous Close $24.31    52 Week High
Open $24.89    52 Week Low
Day High $27.28    P/E N/A 
Day Low $24.59    EPS
Volume 3,579,344